In contrast, the densities of CD4+ and CD8+ effector T cells were similar in both groups, resulting in a significant increase in Treg/Teff ratio in patients with MASH (Fig. 5B). The gene discussed is CD8A; the disease is metabolic dysfunction-associated steatohepatitis.